JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2003; 41:718-724, doi:10.1016/S0735-1097(02)02956-X
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeman, R. V.
Right arrow Articles by Eagle, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeman, R. V.
Right arrow Articles by Eagle, K. A.

Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors

Rosario V. Freeman, MD, MS*,*, Rajendra H. Mehta, MD, MS, FACC{dagger}, Wisam Al Badr, MD{dagger}, Jeanna V. Cooper, MS{dagger}, Eva Kline-Rogers, RN, MS{dagger} and Kim A. Eagle, MD, FACC{dagger}

* Division of Cardiology, University of Washington, Seattle, Washington, USA
{dagger} Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA



View larger version (26K):

[in a new window]
  		Figure 1 In-hospital deaths (n = 40 patients).

 


View larger version (22K):

[in a new window]
  		Figure 2 Utilization of cardiovascular diagnostic tests and therapeutics across creatinine clearance stratum. Numbers at the top of each bar are the total number of patients within each creatinine clearance stratum, and the percentages represented by each bar are the respective portion of that total number. Black bars = catheterization; white bars = glycoprotein IIb/IIIa antagonist; hatched bars = percutaneous coronary intervention; striped bars = coronary artery bypass graft surgery.

 


View larger version (21K):

[in a new window]
  		Figure 3 Unadjusted and adjusted odds ratios for mortality stratified by creatinine clearance. Black bars = unadjusted; hatched bars = adjusted.

 


View larger version (18K):

[in a new window]
  		Figure 4 Absolute major bleeding event rate and creatinine clearance stratum. The lighter portion of each bar represents the relative proportion that received glycoprotein IIb/IIIa antagonists during hospitalization. Numbers at the top of each bar are the total number of patients within each creatinine clearance stratum, and the percentages represented by each bar are the respective portion of that total number. Hatched bars = did not receive glycoprotein IIb/IIIa antagonists; black bars = received glycoprotein IIb/IIIa antagonists.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.